Cost-effectiveness analysis of directly observed therapy for patients with tuberculosis at low risk for treatment default. [electronic resource]
- American journal of respiratory and critical care medicine Aug 1999
- 582-6 p. digital
Adult Antitubercular Agents--economics California Cost-Benefit Analysis Female Health Resources--economics Humans Male Outcome and Process Assessment, Health Care Patient Compliance Patient Dropouts Recurrence Risk Self Administration--economics Tuberculosis, Pulmonary--drug therapy